These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 14794902)

  • 1. The separation of a protective antigen from a toxin-producing strain of Hemophilus pertussis.
    ROBBINS KC; PILLEMER L
    J Immunol; 1950 Oct; 65(4):393-406. PubMed ID: 14794902
    [No Abstract]   [Full Text] [Related]  

  • 2. Adsorption of protective antigen of Hemophilus pertussis on human red cell stromata.
    PILLEMER L
    Proc Soc Exp Biol Med; 1950 Dec; 75(3):704-5. PubMed ID: 14808372
    [No Abstract]   [Full Text] [Related]  

  • 3. Protective antigen of haemophilus pertussis.
    PILLEMER L; BLUM L; LEPOW IH
    Lancet; 1954 Jun; 266(6825):1257-60. PubMed ID: 13164367
    [No Abstract]   [Full Text] [Related]  

  • 4. On the protective antigen of phase 1 H. pertussis.
    KUWAJIMA Y; MASUI M; SHIMURA N
    Yokohama Med Bull; 1952 Jun; 3(3):131-9. PubMed ID: 13029568
    [No Abstract]   [Full Text] [Related]  

  • 5. Interconnexion between the protective antigen and the histamine-sensitizing factor of Bordetella pertussis.
    JOO I; PUSZTAI Z
    Nature; 1960 Oct; 188():331-2. PubMed ID: 13790658
    [No Abstract]   [Full Text] [Related]  

  • 6. Soluble protective antigen from Bordetella pertussis prepared with sodium desoxycholate.
    BARTA G
    J Immunol; 1963 Jan; 90():72-80. PubMed ID: 13969631
    [No Abstract]   [Full Text] [Related]  

  • 7. Antigens of Bordetella pertussis. III. The protective antigen.
    MUNOZ J; HESTEKIN BM
    Proc Soc Exp Biol Med; 1963 Mar; 112():799-805. PubMed ID: 13936641
    [No Abstract]   [Full Text] [Related]  

  • 8. The separation of the histamine-sensitizing factor from the protective antigens of Bordetella pertussis.
    DOLBY JM
    Immunology; 1958 Oct; 1(4):328-37. PubMed ID: 13610416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the K antigen of H pertussis; its existence and a method of detection.
    SHIMOJO H; ISHII T
    Jpn J Exp Med; 1954 Apr; 24(2):51-7. PubMed ID: 13221349
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the k antigen of Haemophilus pertussis; especially on the so-called S-antigen.
    SOMEYA S; KANEKO Y
    Jpn J Med Sci Biol; 1955 Apr; 8(2):99-108. PubMed ID: 13278103
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the K antigen of Haemophilus pertusis.
    SOMEYA S; KANEKO Y
    Jpn J Med Sci Biol; 1954 Oct; 7(5):445-52. PubMed ID: 14366837
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hemagglutinin of Hemophilus pertussis. II. Characteristics of hemagglutinin extracted from Hemophilus pertussis cultures].
    IVANOVA SP
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Nov; (11):72-7. PubMed ID: 13300900
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hemophilus pertussis hemagglutinin. I. Formation of hemagglutinin in cultures of Hemophilus pertussis and its certain properties].
    IVANOVA SP
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Sep; (9):30-4. PubMed ID: 13282449
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of crude toxin of Hemophilus pertussis and anti-crude toxin sera on infection with Hemophilus pertussis. I. Effects of pretreatment with crude toxin of Hemophilus pertussis and its anti-crude toxin sera on pulmonary infection with Hemophilus pertussis].
    KOBAYASHI K
    Paediatr Jpn; 1961; 65():293-300. PubMed ID: 13757276
    [No Abstract]   [Full Text] [Related]  

  • 15. A rapid ELISA-based method for screening Bordetella pertussis strain production of antigens included in current acellular pertussis vaccines.
    Barkoff AM; Guiso N; Guillot S; Xing D; Markey K; Berbers G; Mertsola J; He Q
    J Immunol Methods; 2014 Jun; 408():142-8. PubMed ID: 24925807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of crude toxin of Hemophilus pertussis and anti-crude toxin sera on infection with Hemophilus pertussis. II. Effects of repeated pretreatments with crude toxin of Hemophilus pertussis and effects of anti-vaccine sera and the anti-crude sera on infection with Hemophilus pertussis].
    KOBAYASHI K
    Paediatr Jpn; 1961; 65():301-8. PubMed ID: 13757277
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemophilus pertussis soluble antigen and complement fixing antibodies.
    PARFENTJEV IA; VIRION ME
    J Immunol; 1948 Sep; 60(1):167-71. PubMed ID: 18881078
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experience in diffusion analysis of antigens and antibodies. III. Study of hemophilus pertussis antigens].
    CHISTOVICH GN
    Zh Mikrobiol Epidemiol Immunobiol; 1956 Apr; 27(4):17-22. PubMed ID: 13338794
    [No Abstract]   [Full Text] [Related]  

  • 19. A soluble antigen of phase 1 Hemophilus pertussis. I. Mouse protection test of filtrate or supernatant of cultures in a medium without soluble starch or carbon particles.
    KUWAJIMA Y; MASUI M; ASANO A; MATSUI T
    J Immunol; 1956 Mar; 76(3):175-80. PubMed ID: 13306951
    [No Abstract]   [Full Text] [Related]  

  • 20. Protective antigens of Bordetella pertussis mouse-protection test against intracerebral and aerosol challenge of B. pertussis.
    Sato H; Sato Y
    Dev Biol Stand; 1985; 61():461-7. PubMed ID: 2872127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.